We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

International Remote Imaging Plans Name Change

By HospiMedica staff writers
Posted on 08 Oct 2003
Assuming the required shareholder approval is received, International Remote Imaging Systems, Inc. More...
(IRIS, Chatsworth, CA, USA) will change its name to IRIS International, Inc., according to a company announcement.

IRIS is a manufacturer and marketer of automated in vitro diagnostic urinalysis systems and medical devices for hospitals and clinical laboratories. The company recently introduced its new IQ 200 system, a fully automated urine chemistry and microscopic analyzer. IRIS has a worldwide network of distributors covering 18 countries and has established a European subsidiary. The company's Iris Diagnostics Division is prominent in automated urinalysis technology, with workstations in major medical institutions throughout the world, and its patented technology and recognition software have made significant reductions in the cost and time required for manual microscopic analysis.

"With a new flagship product, updated manufacturing facilities, and new customers around the world, it is appropriate that the company has a new name,” said Dr. Kshitij Mohan, CEO. "It will further strengthen our brand and recognition among our customers and within the investment community.” IRIS has two subsidiaries, StatSpin (sample preparation for blood analysis products, Norwood, MA, USA) and Advanced Digital Imaging Research (proprietary imaging research, Houston, TX, USA).




Related Links:
IRIS

Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.